Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1G | O43497 | 4/20 | 0.42 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.42 |
| ▸ | C5AR1 | P21730 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | UBE2N | P61088 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1832947 | 0.88 | CACNA1G (0.38) | CACNA1GCACNA1HCYP3A4MEN1KMT2A | |
| SCHEMBL3811734 | 0.84 | SIGMAR1 (0.41) | CACNA1GCACNA1H | |
| SCHEMBL4681520 | 0.84 | CHRM5 (0.38) | CACNA1GCACNA1HMEN1KMT2AALDH1A1 | |
| SCHEMBL3398324 | 0.82 | OPRK1 (0.43) | CYP2D6ALDH1A1SLC18A3LMNAKDM4E | |
| SCHEMBL3398294 | 0.82 | OPRK1 (0.43) | CYP2D6ALDH1A1SLC18A3LMNAKDM4E | |
| SCHEMBL4736833 | 0.80 | CACNA1G (0.44) | CACNA1GCACNA1HC5AR1CYP3A4CYP2D6 | |
| SCHEMBL3721847 | 0.79 | C5AR1 (0.40) | CACNA1GCACNA1HC5AR1CYP3A4CYP2D6 | |
| SCHEMBL1838526 | 0.77 | KDM4E (0.43) | CYP2D6ALDH1A1KDM4E | |
| SCHEMBL1838770 | 0.76 | OPRM1 (0.46) | CYP3A4ALDH1A1KDM4E | |
| SCHEMBL1841721 | 0.76 | OPRM1 (0.46) | CYP3A4ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155676-A2 | COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS | Commissariat à l'Energie Atomique (FR) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008146172-A2 | COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-12-04 | — | — | WO | disclosed |
| EP-1997805-A1 | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans | Commissariat à l'Energie Atomique (FR) | 2008-12-03 | — | — | EP | disclosed |